SHANGHAI, April 9, 2024 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a ...
BioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with the latter’s Keytruda (pembrolizumab) in a global Phase I/II trial for ...
WUXI, China, Aug. 7, 2023 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a ...
SHANGHAI, March 13, 2025 /PRNewswire/ -- BioCity Biopharmaceutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that it has entered into a clinical trial collaboration ...
BioCity, a pioneering life science incubator and business collective, today announced an investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures.
BioCity Biopharma (BioCity), a clinical-stage biopharmaceutical company, announced its endothelin receptor type A (ETA) selective antagonist SC0062 met the primary endpoint of proteinuria reduction in ...
SHANGHAI, July 8, 2024 /PRNewswire/ -- BioCity Biopharma (BioCity) announced its endothelin receptor type A (ETA) selective antagonist SC0062 met the primary endpoint of proteinuria reduction in the 2 ...
BioCity, a pioneering life science incubator and business collective, has announced a new strategic partnership with Oxford AHSN. Working in partnership, the Oxford Academic Health Science Network and ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. When BioCity Nottingham, the UK’s biggest biomedical business incubator, opened just over five years ago, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback